Prevention and management of BK-virus associated... (2008 study) Skip to main content
Systematic Review Br J Haematol 2008

Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation--a systematic review and evidence-based guidance for clinical management

Harkensee C, Vasdev N, Gennery A, Willetts I, Taylor C, Br J Haematol, 2008

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

The researchers searched the medical literature on bleeding bladder inflammation in children after stem cell transplants and wrote evidence-based guidelines for prevention and treatment.

What They Found

This systematic review found that the evidence for the most commonly used treatments of haemorrhagic cystitis in children after stem cell transplant is very limited. Those treatments included cidofovir, oestrogen, hyperbaric oxygen, and bladder instillation with formalin, alum salts or prostaglandin. The review noted that some of these treatments also carry significant risks. Higher level evidence exists only for MESNA and hyperhydration as prevention, and for systemic recombinant Factor VII to stop acute bleeding. The abstract reports no figures such as patient numbers or outcome rates.

What This Means for Canadian Patients

For children with haemorrhagic cystitis after a stem cell transplant, the abstract lists hyperbaric oxygen among several commonly used treatments whose supporting evidence is very limited. It does not describe a hyperbaric protocol, pressure or number of sessions, and it does not say whether hyperbaric oxygen works. Families should talk with their transplant team about which options have the strongest evidence.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The review found that the evidence for most treatments, including hyperbaric oxygen, was very limited, so the guidance rests on weak data, and the authors state that high-quality studies are still required to establish effective and safe options.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Systematic Review
Category Systematic Reviews
Source Pubmed
PubMed ID 18540939
Year Published 2008
Journal Br J Haematol
MeSH Terms Administration, Intravesical; Anti-Infective Agents; Antiviral Agents; BK Virus; Child; Cystectomy; Cystitis; Embolization, Therapeutic; Estrogens; Evidence-Based Medicine; Factor VIIa; Fibrin Tissue Adhesive; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Hydrostatic Pressure; Hyperbaric Oxygenation; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Protective Agents

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology